Dudley DT - Search Results

1

Structure-activity relationships of C-terminal endothelin hexapeptide antagonists.

Doherty AM, Cody WL, DePue PL, He JX, Waite LA, Leonard DM, Leitz NL, Dudley DT, Rapundalo ST, Hingorani GP, et al. Doherty AM, et al. Among authors: dudley dt. J Med Chem. 1993 Sep 3;36(18):2585-94. doi: 10.1021/jm00070a001. J Med Chem. 1993. PMID: 8410970

2

Design of a functional hexapeptide antagonist of endothelin.

Cody WL, Doherty AM, He JX, DePue PL, Rapundalo ST, Hingorani GA, Major TC, Panek RL, Dudley DT, Haleen SJ, et al. Cody WL, et al. Among authors: dudley dt. J Med Chem. 1992 Aug 21;35(17):3301-3. doi: 10.1021/jm00095a029. J Med Chem. 1992. PMID: 1324321 No abstract available.

3

The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901.

Barrett SD, Bridges AJ, Dudley DT, Saltiel AR, Fergus JH, Flamme CM, Delaney AM, Kaufman M, LePage S, Leopold WR, Przybranowski SA, Sebolt-Leopold J, Van Becelaere K, Doherty AM, Kennedy RM, Marston D, Howard WA Jr, Smith Y, Warmus JS, Tecle H. Barrett SD, et al. Among authors: dudley dt. Bioorg Med Chem Lett. 2008 Dec 15;18(24):6501-4. doi: 10.1016/j.bmcl.2008.10.054. Epub 2008 Oct 15. Bioorg Med Chem Lett. 2008. PMID: 18952427

4

Subclasses of angiotensin II binding sites and their functional significance.

Dudley DT, Panek RL, Major TC, Lu GH, Bruns RF, Klinkefus BA, Hodges JC, Weishaar RE. Dudley DT, et al. Mol Pharmacol. 1990 Sep;38(3):370-7. Mol Pharmacol. 1990. PMID: 2402226

5

The role of arachidonic acid in the secretion of the amyloid precursor protein (APP).

Emmerling MR, Dudley DT, Dyer RD, Carroll RT, Doyle PD, Davis RE. Emmerling MR, et al. Among authors: dudley dt. Ann N Y Acad Sci. 1996 Jan 17;777:310-5. doi: 10.1111/j.1749-6632.1996.tb34438.x. Ann N Y Acad Sci. 1996. PMID: 8624105

6

Characterization of angiotensin II (AT2) binding sites in R3T3 cells.

Dudley DT, Hubbell SE, Summerfelt RM. Dudley DT, et al. Mol Pharmacol. 1991 Sep;40(3):360-7. Mol Pharmacol. 1991. PMID: 1896025

7

Amylin increases cyclic AMP formation in L6 myocytes through calcitonin gene-related peptide receptors.

Zhu GC, Dudley DT, Saltiel AR. Zhu GC, et al. Among authors: dudley dt. Biochem Biophys Res Commun. 1991 Jun 14;177(2):771-6. doi: 10.1016/0006-291x(91)91855-7. Biochem Biophys Res Commun. 1991. PMID: 1646609 Free article.

8

Design and synthesis of phenethyl benzo[1,4]oxazine-3-ones as potent inhibitors of PI3Kinasegamma.

Lanni TB Jr, Greene KL, Kolz CN, Para KS, Visnick M, Mobley JL, Dudley DT, Baginski TJ, Liimatta MB. Lanni TB Jr, et al. Among authors: dudley dt. Bioorg Med Chem Lett. 2007 Feb 1;17(3):756-60. doi: 10.1016/j.bmcl.2006.10.080. Epub 2006 Oct 28. Bioorg Med Chem Lett. 2007. PMID: 17095227

9

Regulated expression of angiotensin II (AT2) binding sites in R3T3 cells.

Dudley DT, Summerfelt RM. Dudley DT, et al. Regul Pept. 1993 Mar 19;44(2):199-206. doi: 10.1016/0167-0115(93)90243-2. Regul Pept. 1993. PMID: 8469774

10

A synthetic inhibitor of the mitogen-activated protein kinase cascade.

Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. Dudley DT, et al. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7686-9. doi: 10.1073/pnas.92.17.7686. Proc Natl Acad Sci U S A. 1995. PMID: 7644477 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page